Cite
MLA Citation
N. Daver et al.. “A phase II open‐label study of the intravenous administration of homoharringtonine in the treatment of myelodysplastic syndrome.” European journal of cancer care, vol. 22, n.d., pp. 605–611. http://access.bl.uk/ark:/81055/vdc_100024538934.0x000007